Jianhai Technology Funding, Investors & Competitors

Jianhai Technology has raised $125M across 4 funding rounds, most recently a $78M Series B in November 2021.

Last Jianhai Technology funding round

$78M

Series B · Nov 2021

Cumulative funding Jianhai Technology raised

$125M

across 4 funding rounds

Key investors in Jianhai Technology

  • Sherpa Healthcare Partners
  • HSG
  • Source Code Capital
  • iFlytek
  • Haibang Capital
  • Huasheng Capital
  • Panorama Capital
  • Sanzheng Health

Jianhai Technology Overview

About Jianhai Technology

Jianhai Technology is a Chinese AI platform providing whole-course management services for post-hospital and post-diagnosis care, supporting patient monitoring and health data analysis.


Founded

2015

HQ

ChinaHangzhou

Status

Privately held

Customer focus

B2B

Revenue model

Services, Subscription

Jianhai Technology Funding History

Jianhai Technology has raised a total of $125M across 4 funding rounds.

Jianhai Technology's first fundraising round was a $15M Series A in July 2019. The most recent completed round was a $78M Series B in November 2021.

Jianhai Technology funding rounds

Jianhai Technology funding rounds
DateStageInvestorsRaisedDeal Summary
Nov 2021Series BHuasheng Capital; Sherpa Healthcare Partners; Sanzheng Health; HSG; Panorama Capital$78M-
Mar 2021Series BHSG (lead); Sherpa Healthcare Partners; Source Code Capital$23MHangzhou Jianhai Technology Co., Ltd. develops digital health solutions focused on post-disease management, including digital therapy platforms that integrate with hospital workflows for patient engagement and care delivery. The company operates a B2B subscription-based model, partnering with over 1,000 hospitals to provide access to online doctor networks and disease management tools. Its offerings target streamlining post-discharge processes in traditional healthcare settings. A January 2022 Series B raised CNY 150 million led by Sequoia Capital with Sherpa and Source Code participation. The company plans fund use for R&D expansion, clinical trials, personnel, new products, and geographic growth.
Sep 2020Series ASherpa Healthcare Partners; Source Code Capital$9M-
Jul 2019Series ASherpa Healthcare Partners; iFlytek; Haibang Capital$15M-

Who has invested in Jianhai Technology?

8 investors have backed Jianhai Technology across its funding rounds, including Sherpa Healthcare Partners, HSG, Source Code Capital, iFlytek, Haibang Capital and Huasheng Capital.

Lead investors include HSG.


Jianhai Technology Investors

Investors in Jianhai Technology by funding rounds participated
InvestorHQRoundsRoleFirst check
Sherpa Healthcare PartnersChinaBeijing4ParticipantJul 2019
HSGHong KongHong Kong2LeadMar 2021
Source Code CapitalChinaChaoyang2ParticipantSep 2020
Huasheng CapitalChinaShanghai1ParticipantNov 2021
iFlytekChinaHefei1ParticipantJul 2019
Sanzheng Health--1ParticipantNov 2021

This data is available for Pro users. Sign up to see all 8 Jianhai Technology investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Jianhai Technology Competitors

Jianhai Technology competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.

Public and private companies comparable to Jianhai Technology
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
IQVIAUnited StatesUnited StatesPublicly listed$16B$3.4B$44B3.4x
VeevaUnited StatesUnited StatesPublicly listed$3.2B$965M$43B10.2x
IDEXX LaboratoriesUnited StatesUnited StatesPublicly listed$4.3B$1.5B$40B8.9x
Roper TechnologiesUnited StatesUnited StatesPublicly listed$7.9B$3.2B$37B5.7x
CommureUnited StatesSan Francisco, CAPrivate$200M-$7B35.0x
DoctolibFranceParisPrivate$400M-$6.4B16.0x

Jianhai Technology Public Comps

Jianhai Technology is still privately-owned, but its public comps include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging, Glaukos and M3 Inc..

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Veeva$3.2B$965M11.1x10.2x36.9x22.4x
IDEXX Laboratories$4.3B$1.5B9.5x8.9x27.1x24.9x
Roper Technologies$7.9B$3.2B6.1x5.7x15.2x14.6x
GE HealthCare$21B$3.7B1.8x1.8x10.1x10.0x
ICON plc$8.3B$816M1.9x1.9x19.2x11.3x
Pro Medicus$186M$147M66.6x62.7x84.4x77.6x
United Imaging$2.1B$367M5.5x4.8x30.7x26.9x

This data is available for Pro users. Sign up to see all Jianhai Technology competitors and their valuation data.

Start Free Trial

Common questions about Jianhai Technology

When was Jianhai Technology founded?Jianhai Technology was founded in 2015.
Where is Jianhai Technology headquartered?Jianhai Technology is headquartered in Hangzhou, China.
Is Jianhai Technology publicly listed?No, Jianhai Technology is a private, VC-backed company.
How much funding has Jianhai Technology raised?Jianhai Technology has raised $125M across 4 funding rounds.
What was Jianhai Technology's last funding round?Jianhai Technology's last funding round was a $78M Series B in November 2021.
Who are Jianhai Technology's investors?Jianhai Technology's investors include Sherpa Healthcare Partners, HSG, Source Code Capital, Huasheng Capital, iFlytek, Sanzheng Health, Haibang Capital and Panorama Capital.
Which companies are comparable to Jianhai Technology?Companies comparable to Jianhai Technology include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib.

See companies similar to Jianhai Technology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial